Abstract PO3-09-09: Interventions to improve adherence to oral endocrine therapy for prevention or treatment of breast cancer in African American women of low socioeconomic status
Camille S. Johnson(University of Houston), Meghana V. Trivedi(University of Houston), Bilqees Fatima(University of Houston), Susan Abughosh(University of Houston), Keith Houk(University of Houston), Onyebuchi Ononogbu(University of Houston), Zahra Majd(University of Houston), Ann Adigwe(University of Houston), Rob Shimko(University of Houston), Nicole Ekezie(University of Houston), Tejal Patel
Cited by 0
Related Papers
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize
|Cancer Research|2018|221
Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications
|Breast Care|2013|200
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
|Proceedings of the National Academy of Sciences|2016|185
The changing role of ER in endocrine resistance
|The Breast|2015|133